ZYDREXAFIL Trademark

Trademark Overview


On Friday, March 29, 2024, a trademark application was filed for ZYDREXAFIL with the United States Patent and Trademark Office. The USPTO has given the ZYDREXAFIL trademark a serial number of 98475545. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, October 17, 2024. This trademark is owned by Pureform Nutraceuticals LLC. The ZYDREXAFIL trademark is filed in the Pharmaceutical Products category with the following description:

dietary and nutritional supplements
zydrexafil

General Information


Serial Number98475545
Word MarkZYDREXAFIL
Filing DateFriday, March 29, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, October 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesdietary and nutritional supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 29, 2024
Primary Code005
First Use Anywhere DateWednesday, February 7, 2024
First Use In Commerce DateWednesday, February 7, 2024

Trademark Owner History


Party NamePureform Nutraceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSheridan, WY 82801

Trademark Events


Event DateEvent Description
Friday, March 29, 2024NEW APPLICATION ENTERED
Friday, March 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 10, 2024ASSIGNED TO EXAMINER
Thursday, October 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 17, 2024NON-FINAL ACTION E-MAILED
Thursday, October 17, 2024NON-FINAL ACTION WRITTEN